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ALTERED L-METHIONINE S35 UTILIZATION IN PSORIASIS*
MORRIS J. LIPNJK, M.D.t AND STANLEY H. LEVY, M.D4
The etiology of psoriasis, one of the commonest
skin diseases, remains as a challenge to the
investigator of dermatologic diseases. In the past
year Flesch and Jackson Esoda (1) described a
peculiarity in the scales of psoriasis. Of particular
interest was the fact that the scales showed an
abnormally high sulfhydryl content and a low
amino nitrogen content, limited to the water
soluble portion of the scale. It appeared from our
knowledge of keratinization (2) that there was
incomplete keratinization occurring in psoriasis
that resulted in the change iii the scale. Steiner
(3) was able to show that psoriatic diseased skin
contained an abundance of thiol (Sil) material,
by histologic studies, utilizing differential staining
technics.
To study the metabolic aspects of psoriasis we
felt that the most fruitful source of investigation
should begin with a study of the body's kinetics
in the utilization of sulfur compounds. Rather
than concentrate our attention on the scale, the
end-product of the disease, we chose to study the
epidermis by an in vivo method. We chose as a
test substance a physiologic compound, one of the
simple sulfur-containing essential amino acids,
methionine. We utilized the biologically active
form of this compound, namely, the L form. The
radioactive S35 isotope of L-methionine was used
as a tracer substance. This sulfur isotope is a
pure beta emitter and the isotope's presence after
ingestion could be tracked by counts of radio-
activity of the skin surface. Studies were per-
formed on psoriasis patients and control patients
after oral feeding of this tracer compound.
METHOD AND MATERIALS
Two test groups of patients were utilized in
this study. One group consisted of patients with a
severe form of psoriasis. This group totaled nine
patients, in ages between thirty and sixty-four
and was composed of four females and five males.
All of the psoriasis patients had a generalized
form of the disease with plaques of a minimum
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diameter of 2.5 cm. They were all outpatients.
Four were tested prior to any attempt towards
therapy of their disease. The control test group
numbered fourteen, in ages between twenty and
sixty-nine and was composed of three females and
eleven males. All the control patients were hospi-
tal inpatients. The control group was free of any
skin disease.
A radioisotope of sulfur was used as a tracer
compound. We used as a test substance the
essential amino acid L-methionine labeled as
535 § The radioisotope S35 is a pure beta emitter.
It has a half life of 87.1 days and emits beta rays
of an intensity of 0.166 mev. It had a specific
activity of 27 millicuries per gram of methionine.
The patients were given the tracer substance
L-methionine 535 dissolved in water. Doses given
were 40 uc. to each patient, according to the
method outlined by Sandweiss and Levy (4).
The test substance was given at 8:00 A.M. to
the test subjects in the fasting state. They were
given a standard breakfast five hours later.
Thereafter, no effort was made to control their
dietary intake. Tests were performed of the skin
of subjects receiving the test compound.
A standard procedure was utilized in testing
for radioactivity. Prior to testing, the area to be
tested on both normal and diseased skin, was
cleared of scale by rubbing lightly with a tongue
blade applicator. activity in the skin was
determined through the use of a thin-window
TGC-2 Geiger tube. The skin was scanned for
five minutes with this tube, placed 3- inch from
the skin, utilizing constant geometry (5). Mul-
tiple readings were taken and averaged. No
effort was made to calculate the radioactive
decay level of the isotope, as this factor was
constant in both controls and psoriatics. Patients
with psoriasis had tests performed on both their
clear skin and on a patch of diseased skin. The
test site for the controls and for psoriatic clear
skin was the subscapular area. If a psoriatie
patch was present on the back in this area it was
used as the test site. When there were no psoriatic
patches of large enough size on the back, non-
§ Obtained from the Abbott Laboratories, North
Chicago, Illinois.
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hairy areas elsewhere on the body were used. In
no case was the scalp used as a test site. The
same site was utilized for the repeat tests on the
same individual. Counts were taken hourly for
the first five hours after administration of the
test compound. Subsequent counts were made at
twenty-four intervals for the next seven days.
One patient was tested for nine days.
RESULTS
I—P8oriatic Diseased Skin
The data of these experiments was striking in
showing an avid retention by the psoriatic skin
of the radioisotope of sulfur. In Table 1 are listed
the comparative values of the psoriasis patients'
diseased and clear skin. The first patient we
tested, T.L., showed sulfur retention by the
diseased skin for nine days (at which time we
stopped our test). All of the psoriasis patients
showed measurable quantities of the radioiso-
tope S25 for seven days in the patches of diseased
skin. The diseased skin counts after the first
twenty four hours ranged from 173 to 635 per
five minutes. The peak counts were reached in
three to four days. The diseased skin peak counts
were two to six times that of the controls.
Ii Control—Psoriatic Clear Skin
The clear skin in the psoriatic showed low
levels of retention of the radioactive sulfur. The
peak counts occurred two to four hours after
feeding of the tracer compound. The counts
after twenty four hours ranged from 50 to 180
per five minutes. By the conclusion of the third
day over half of this group showed no remaining
radioisotope. Subsequently, progressively de-
creasing low levels were present in those who
showed further retention of the radioisotope. The
psoriatic clear skin group was much the same as
the normal skin group, except for a persistence
of low levels of the radioisotope for a longer period
in some of the members of the psoriatic clear
skin group.
III Control—Wormal Skin
The counts of the fourteen control patients
free of skin disease are presented in Table 2. In
this group the peak counts were reached rapidly
after the ingestion of the tracer substance. The
peak occurred in two to four hours. This is
similar to psoriatic clear skin. After twenty four
hours low levels of radioactive sulfur were present,
in the range of 70 to 150 counts per five minutes.
A point of difference in this group was that five
of the fourteen tested showed no sulfur isotope
remaining on the skin when tested twenty four
hours after the oral test dose. The entire group
showed no isotope remaining after three days.
Table 3 condenses the above data by presenting
the average values for comparison. This is shown
graphically by Figure 1. Demonstrable high
TABLE 2
Control subjects (14): True counts of 535/5 minutes of skin after oral feeding of 40 jLc. of L-methionine $36
Subject Age Sex Wt. Hr. 1 Hr. 15 Hr. 2 Hr. 2.4 Hr. 3 Hr. 4 Hr. 5 Hr.
M.C. 45 F 110 —' 90 180 — 190 180 — 112 99 NSt
C.V. 64 M 143 — 84 — 121 — 102 95 60 NS NS NS
D.C. 20 M 174 40 60 74 111 — 95 85 110 NS NS NS
M.B. 43 M 125 — 136 — 200 — 171 170 — 144 128 NS
M.S. 46 M 91 40 50 60 87 — 138 120 — 90 90 NS
R.L. 50 M 180 — 100 — 156 — 163 112 92 NS NS NS
W.G. 69 M 134 — 82 — 141 — 150 159 140 NS NS NS
G.B. 53 M 172 — 80 — 140 — 141 157 122 110 NS NS
H.B. 68 M 161 — 90 — 139 — 151 148 110 90 NS NS
I.P. 47 F 157 — 95 — 110 — 137 140 133 120 100 NS
C.V. 64 M 143 60 90 100 135 150 196 203 180 150 90 NS
S.S. 66 M 80 — 50 98 150 135 129 100 100 70 NS NS
I.F. 43 F 133 — 69 — 130 — 160 152 130 NS NS NS
R.T. 61 M 159 40 60 — 120 — 140 170 158 — — —
* Not counted.
t Quantity insufficient for measurement.
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TABLE 3
Comparison of true counts of skin (average) of 9 psoriatic patients and 14 controls after oral feeding of
L-methionine-,S'35
4Hr.l 1 Hr. 2 Hr. 3 Hr. 4 Hr. 5 r. 2ndDay 3rdDay 4thDay 5thDay 6thDay 7thDay
Psoriasis diseased skin
Psoriasis clear skin
Control clear skin
90 112
89 1108
45 81
147
132
137
167
125
147
200
106
142
235
112
121
310
107
111
443
104
101
450
99*
NS
398
hOt
NS
331
70
NS
284
NS
NS
* Average of 4 of 9 subjects with others showing no radioactivity.
f Average of 2 of 9 subjects with others showing no radioactivity.
Average of 2 of 9 subjects with others showing no radioactivity.
§ NS—Insufficient quantity for measurement.
DISCUSSION
The uptake of a radioisotope varies with the
tissue tested and the chemical nature of the iso-
tope. J131 tends to be attracted to thyroid, salivary
and gastric secretory glands. Radioactive phos-
phorus is localized chiefly in bone. Radioactive
sulfur shows its greatest concentration in cartilage
and growing bone. The skin levels of absorption
of S35 would be classified as moderate in degree
(6). In testing with radioactive sulfur, those
tissues that utilize sulfur will rapidly take up the
radioactive material, because the body cannot
distinguish in its metabolic processes between
stable and radioactive elements.
When the radioactive sulfur of L-methionine
S35 is absorbed into the blood stream after oral
feeding and the radioisotope is in the plasma, it
will be available to all tissues in a useable form.
The tissues of psoriatic diseased skin seems to
have an affinity for the radioisotope. What the
exact nature of the physiochemical process that
controls this attraction is unknown. Bostrom and
Masson (7) demonstrated that uptake of radio-
sulfur in cartilage is a function of living tissue.
They felt that it was probably enzymatic as no
uptake of S35 occurred in boiled cartilage.
The nature of the S35 isotope is such that it is a
weak beta emitter. Its penetration level through
the epidermis is at maximum 0.8 mm. It must be
recognized that in our counts of normal skin and
psoriatic clear skin, the counts are those of the
entire epidermal layer. Psoriatic patches, how-
ever, show elongation of the rete pegs. It is prob-
able that the counts of the psoriasis diseased skin
are not of the complete thickness of the epidermis
because measurement cannot be made of the
extreme depths of the psoriatic rete pegs with the
sulfur radioisotope.
PSORJATIC
DISEASED
PSORIATI C
CLEAR
501
400
300
'-' 201
I.Lj
=I-
700
1 2 3 4 5 24 48 72 96 120 144
HOURS
Fia. 1. Oral feeding of L-methionine S5. Com-
parison of average skin S35 counts in psoriatics'
diseased skin (9) and clear skin (9) and normal
skin controls (14).
counts can be seen in the psoriatic patches for the
seven day test period. At the end of seven days
the diseased skin still maintained twice the 535
as the average peak count of the controls.
No correlation can be drawn from these studies
with regards the amount of radio-sulfur retention
and the severity of the disease process. Patient
T.L. had the greatest degree of skin involvement
yet she did not have the highest skin counts.
The patient M.G. presented the lowest count,
yet had moderately severe skin involvement
and psoriatic arthritis.
s35 IN PSORIASIS 523
There is one recent study of the skin by the
use of a radioisotope of sulfur. This study con-
cerned scieroderma and morphea. Denko and
Stoughton (8) reported their observations follow-
ing the use of an inorganic compound containing
S, Na2S5O. They used an intravenous dose of
2000 zc. as compared with our oral dose of 40 tic.
Their technic for determining radioactivity was
different. They performed biopsy examinations of
the diseased sites and incinerated the tissue, per-
forming counts of the ash, as contrasted to our
method of counts of the epidermal surface. Their
results showed increased storage in two of the
three cases of scieroderma after three weeks, and
decreased S storage in morphea. From the
acellularity present in both morphea and sciero-
derma, it is our belief that a comparative study
by the method we used would not reveal any
increase of the surface counts in either sclero-
derma or morphea.
The altered utilization of L-methionine S35
appears as a retention of the radioisotope by the
diseased skin of the patches of psoriasis. This
affinity for sulfur does not involve the clear skin
of the psoriatic. The cause for this sulfur retention
by the skin of the psoriatic patch is unknown.
There is considerable speculation that there is an
enzyme deficiency in psoriatic skin but no con-
clusive investigative studies. Paschoud and
Schmidli (9) feel that there is a polypeptidase
deficiency in the patches of psoriatic skin. Steiner
(3) postulates that there is a low dehydrogenase
level in psoriatic skin. Kuta and Neumann (10)
found the opposite to be true in their investigative
study. They found high values of succirdc de-
hydrogenase present in the psoriatic papule and
in skin experimentally irritated to produce the
Koebner phenomenon. The findings of Rony and
associates (11) concerning the presence in the
skin of a sulfhydryl oxidase enzyme system may
be applied to understand the defect of psoriatic
skin. They postulate the presence of accelerators
and inhibitors of this system to exist in normal
skin. If an inhibitor is present in psoriatic skin,
this could account for our findings of sulfur reten-
tion. Sizer's (12) recent discussion of enzyme
inhibitors is helpful in understanding the possibil-
ity that such a defect might be present in psori-
asis.
The sulfur retention by the psoriatic skin
demonstrated in this study could be caused by
extra-derinal as well as dermal causation.
'Whether this retention is the result of a deficient
enzyme system, a missing co-enzyme, an inhibitor
of the sulfhydryl oxidase system, of some addi-
tional specific enzyme system inherent in psori-
asis, or an unknown enzyme system of the skin, is
an avenue of investigation that must be pursued
to discover the ultimate cause of this disease.
The metabolic end-product that resulted
from the oral feeding of the radioisotope was not
identified. For this reason and because the unit
of measurement was radio-sulfur35 we have re-
ported all of our findings as sulfur, but we are
fully aware that we are not dealing with elemental
sulfur in the patches of psoriatic skin.
SUMMARY
Nine patients with severe psoriasis and four-
teen control patients free of skin disease were
tested for the kinetics of sulfur metabolism of the
skin by oral feeding of a tracer substance L-methi-
onine Studies by measurement of counts of
radioactivity were performed on the skin surface
with a Gieger tube. Significant differences were
observed, on comparison of psoriatic diseased
skin with psoriatic clear skin and normal skin
controls. The psoriasis patients demonstrated
sulfur retention in the patches of diseased skin
when compared to controls. Within five hours
after the oral test dose of L-methionine S35 the
psoriasis patch shows an increased count of sul-
fur35 above that of both the control without skin
disease and the psoriatic clear skin. The psoriasis
patch continues to accumulate the sulfur isotope.
By the fifth day the psoriatic patch shows two
to six times the level of controls. In our mode of
testing we were careful to scrape the scales off of
the lesions daily, undoubtedly removing some of
the isotope. Moreover, the keratinization rate is
increased in psoriasis, with large quantities of
scales produced daily. This should result in a
further drain of the available resources of sulfur
groups. In spite of this, relatively large amounts
of radioactive persisted in the epidermal layer
of the psoriasis plaques at the end of the seven
day test period.
Even in consideration of the obvious fact that
the parakeratotic and thickened stratum corneum
of psoriatic skin is a repository site that differs
from the normal epidermal covering of clear
skin and that the weak emission of the S35 beta
ray failed to measure the extreme depths of the
elongated rete pegs, we feel that there is demon-
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strated a defective metabolism of sulfur-eon-
taming compounds in psoriasis.
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